Alcon (ALC) to acquire LumiThera

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GOOGL
8. GMAB
9. USO
10. AMD

Go back to Alcon (ALC) to acquire LumiThera

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

July 7, 2025 8:00 AM EDT

LumiTheras photobiomodulation (PBM) device is the first and only technology that has demonstrated meaningful visual improvement with two years of treatments* in early and intermediate dry AMD patients1,2 Nearly 200 million people globally live with dry AMD, a progressive disease with no cure, and a leading cause of blindness in developed nations3,4 Alcon aims to expand PBM office-based treatment in approved markets, underscoring its commitment to people living with retinal diseases

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in... More